Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Zapien Productos Hand Sanitizer Gel Antibacterial Recalled by GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION Due to cGMP deviations: Product made at the same facility...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION directly.
Affected Products
Zapien Productos Hand Sanitizer Gel Antibacterial, 33.8 FL. OZ (1000 mL), Made by GAZA S.A. DE C.V. Castilla St. #1473-A ZIP 45410 Tonala, Jalisco, Mexico, UPC: 7 501700 623504, NDC numbers: 76938-001-01, 76938-001-02, 76938-001-03.
Quantity: 43875 liters
Why Was This Recalled?
cGMP deviations: Product made at the same facility where product tested was sub-potent.
Where Was This Sold?
This product was distributed to 1 state: TX
About GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION
GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION has 2 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report